Skip to main content
Caplight Logo









Unravel Health

Unravel Health

Private
LondonHealthcare & Life Scienceshttps://unravel.health/

Last Round

Grant

Feb 20, 2025

Total Funding Raised

$161,250

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Unravel Health is a health technology company that develops a non-invasive, at-home saliva monitoring device to track hormonal patterns and biomarkers for women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT, D2C Brands, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

femtechat-home hormone testingsaliva monitoringhormonal healthbiomarker trackingwomen's health techdiagnostic hardwarehealth IoTpersonalized health insightshormone analyticsPCOS managementperimenopause trackingdigital healthdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unravel Health Comparables

Compare Unravel Health with similar companies based on industry and business-model similarity.

Unravel Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hormona
84%
Eli Health
84%
Mint Diagnostics
79%

Unravel Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 20, 2025
AcceleratorDec 3, 2024
AcceleratorOct 25, 2024

Unravel Health Investors

Notable investors and investment history

Unravel Health investors
InvestorRounds
STACAccelerator
University of GlasgowAccelerator
SBRI HealthcareGrant
Health Innovation NetworkGrant
NHS Accelerated Access CollaborativeGrant
Central Research LaboratoryAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 60% MoM.

  • Jun 20, 2026

    Monthly visitors increased 37% MoM.

Unravel Health Filings

Explore SEC and related filing metadata, where available.

Unravel Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Unravel Health's valuation, stock price, and market status.

Is Unravel Health a public or private company?

Unravel Health is a private company.

What is the current stock price of Unravel Health?

Unravel Health is a private company with no public stock price. No recent secondary market data is available.

How much is Unravel Health worth (valuation)?

Valuation information for Unravel Health is not publicly available.

Can I buy Unravel Health stock?

Unravel Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Unravel Health's last funding round?

Funding round information for Unravel Health is not publicly available.

Who are the main investors in Unravel Health?

Investor information for Unravel Health is not publicly disclosed.

Will Unravel Health IPO soon?

No public IPO plans have been announced for Unravel Health.

How can I track Unravel Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Unravel Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2024
Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?